The hidden switches underlying RORα-mediated circuits that critically regulate uncontrolled cell proliferation.
暂无分享,去创建一个
Kwang-Hyun Cho | Sung-Young Shin | Dongkwan Shin | Kwang-Hyun Cho | S. H. Baek | Ji Min Lee | Sung-Young Shin | Dongkwan Shin | Ik Soo Kim | Jonghoon Lee | Ji Min Lee | Sung Hee Baek | Jong-Hoon Lee
[1] M. Weller,et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor , 2011, Nature.
[2] L. Gudas,et al. Retinoids, retinoic acid receptors, and cancer. , 2011, Annual review of pathology.
[3] K. Druey,et al. Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-ß-Catenin Signaling Axis , 2005, Science.
[4] S. Narumiya,et al. Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. , 1999, Cancer research.
[5] Hans Clevers,et al. Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors , 2002, Molecular and Cellular Biology.
[6] S. Dey,et al. Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade. , 2005, Cancer research.
[7] A. Moschetta,et al. Nuclear receptors, intestinal architecture and colon cancer: an intriguing link , 2008, Cellular and Molecular Life Sciences.
[8] Y. Sugimoto,et al. Molecular mechanisms of diverse actions of prostanoid receptors. , 1995, Biochimica et biophysica acta.
[9] John D. Minna,et al. Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer , 2010, PLoS medicine.
[10] C. Albanese,et al. The cyclin D 1 gene is a target of the b-catenin y LEF-1 pathway , 1999 .
[11] C. Potten,et al. The effect of exogenous prostaglandin administration on tumor size and yield in Min/+ mice. , 2000, Cancer research.
[12] M. Hull,et al. Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? , 2004, Molecular cancer therapeutics.
[13] Hemant K Roy,et al. AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. , 2002, Carcinogenesis.
[14] Hans Clevers,et al. Caught up in a Wnt storm: Wnt signaling in cancer. , 2003, Biochimica et biophysica acta.
[15] Choun-Ki Joo,et al. Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway , 2002, Molecular and Cellular Biology.
[16] W. de Souza,et al. Prostaglandin E2-EP1 and EP2 receptor signaling promotes apical junctional complex disassembly of Caco-2 human colorectal cancer cells , 2008, BMC Cell Biology.
[17] Rami N. Hannoush,et al. Kinetics of Wnt-Driven β-Catenin Stabilization Revealed by Quantitative and Temporal Imaging , 2008, PloS one.
[18] Hee June Choi,et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes , 2005, Nature.
[19] S. Dey,et al. Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ , 2004 .
[20] T. Hla,et al. Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[21] C. Albanese,et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] Kwang-Hyun Cho,et al. The biphasic behavior of incoherent feed-forward loops in biomolecular regulatory networks. , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.
[23] S. Narumiya,et al. Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. , 2002, Cancer research.
[24] Onn Brandman,et al. Feedback Loops Shape Cellular Signals in Space and Time , 2008, Science.
[25] M. Rosenfeld,et al. RORalpha attenuates Wnt/beta-catenin signaling by PKCalpha-dependent phosphorylation in colon cancer. , 2010, Molecular cell.
[26] M. Wiesmann,et al. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/β-catenin signaling is activated in human colon tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] Heather R. Roberts,et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. , 2009, Carcinogenesis.
[28] Kevin Struhl,et al. An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.
[29] R. DuBois,et al. COX-2: a molecular target for colorectal cancer prevention. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] D. Rodriguez,et al. Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression. , 2009, Molecular biology of the cell.
[31] M. Kay Washington,et al. Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells* , 2001, The Journal of Biological Chemistry.
[32] C. Harris,et al. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. , 2003, Cancer research.
[33] G. Xiong,et al. RORα suppresses breast tumor invasion by inducing SEMA3F expression. , 2012, Cancer research.
[34] Yukihiko Sugimoto,et al. Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth , 2003, The Journal of experimental medicine.
[35] Jack Xin,et al. A Critical Quantity for Noise Attenuation in Feedback Systems , 2010, PLoS Comput. Biol..
[36] A. C. Williams,et al. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer. , 2006, Biochimica et biophysica acta.
[37] D. Kojetin,et al. Regulation of p53 Stability and Apoptosis by a ROR Agonist , 2012, PloS one.
[38] Christopher K. Glass,et al. Exchange of N-CoR Corepressor and Tip60 Coactivator Complexes Links Gene Expression by NF-κB and β-Amyloid Precursor Protein , 2002, Cell.
[39] J. Faivre,et al. Chemoprevention of colorectal cancer. , 1999, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[40] Kwang-Hyun Cho,et al. The regulatory circuits for hysteretic switching in cellular signal transduction pathways , 2012, The FEBS journal.
[41] Kwang-Hyun Cho,et al. A hidden incoherent switch regulates RCAN1 in the calcineurin–NFAT signaling network , 2011, Journal of Cell Science.
[42] B. Rigas,et al. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. , 1995, Biochimica et biophysica acta.
[43] Jens Timmer,et al. Systems-level interactions between insulin–EGF networks amplify mitogenic signaling , 2009, Molecular systems biology.
[44] Kwang-Hyun Cho,et al. The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor. , 2012, Journal of molecular cell biology.
[45] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[46] Kevin Struhl,et al. An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis , 2011, Cell.
[47] Ignacio Rubio,et al. Role of cAMP in the promotion of colorectal cancer cell growth by Prostaglandin E2 , 2008, BMC Cancer.
[48] G. Krishnaswamy,et al. Prostaglandin H synthase expression is variable in human colorectal adenocarcinoma cell lines. , 1997, Experimental cell research.
[49] T. Sugimura,et al. Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis. , 2001, Anticancer research.
[50] T. Sugimura,et al. Enhancement of colon carcinogenesis by prostaglandin E2 administration. , 2003, Carcinogenesis.
[51] E. Gelmann,et al. Molecular biology of the androgen receptor. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] R. DuBois,et al. The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.
[53] A. C. Williams,et al. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence. , 2006, Cancer research.
[54] Frank McCormick,et al. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.
[55] Wendy S. Wright,et al. Wnt Signaling Protects 3T3-L1 Preadipocytes from Apoptosis through Induction of Insulin-like Growth Factors* , 2002, The Journal of Biological Chemistry.
[56] Kwang-Hyun Cho,et al. Attractor Landscape Analysis Reveals Feedback Loops in the p53 Network That Control the Cellular Response to DNA Damage , 2012, Science Signaling.
[57] A. Tarnawski,et al. Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy , 2002, Nature Medicine.
[58] Yukihiko Sugimoto,et al. Host Prostaglandin E 2-EP 3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth , 2003 .
[59] Kwang-Hyun Cho,et al. Dynamics of biological systems: role of systems biology in medical research , 2006, Expert review of molecular diagnostics.
[60] J. Morrow,et al. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. , 1998, Cancer research.